These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 16423804)
1. Administration of optimum sustained-insulin release PLGA microcapsules to spontaneous diabetes-prone BB/Wor//Tky rats. Takenaga M; Yamaguchi Y; Ogawa Y; Kitagawa A; Kawai S; Mizushima Y; Igarashi R; Namae M; Komeda K Drug Deliv; 2006; 13(2):149-57. PubMed ID: 16423804 [TBL] [Abstract][Full Text] [Related]
2. Optimum formulation for sustained-release insulin. Takenaga M; Yamaguchi Y; Kitagawa A; Ogawa Y; Kawai S; Mizushima Y; Igarashi R Int J Pharm; 2004 Mar; 271(1-2):85-94. PubMed ID: 15129976 [TBL] [Abstract][Full Text] [Related]
3. Insulin-loaded biodegradable PLGA microcapsules: initial burst release controlled by hydrophilic additives. Yamaguchi Y; Takenaga M; Kitagawa A; Ogawa Y; Mizushima Y; Igarashi R J Control Release; 2002 Jun; 81(3):235-49. PubMed ID: 12044564 [TBL] [Abstract][Full Text] [Related]
4. Preparation and in vitro/in vivo evaluation of insulin-loaded poly(acryloyl-hydroxyethyl starch)-PLGA composite microspheres. Jiang G; Qiu W; DeLuca PP Pharm Res; 2003 Mar; 20(3):452-9. PubMed ID: 12669968 [TBL] [Abstract][Full Text] [Related]
5. A novel sustained-release formulation of insulin with dramatic reduction in initial rapid release. Takenaga M; Yamaguchi Y; Kitagawa A; Ogawa Y; Mizushima Y; Igarashi R J Control Release; 2002 Feb; 79(1-3):81-91. PubMed ID: 11853920 [TBL] [Abstract][Full Text] [Related]
6. Liraglutide-loaded poly(lactic-co-glycolic acid) microspheres: Preparation and in vivo evaluation. Wu J; Williams GR; Branford-White C; Li H; Li Y; Zhu LM Eur J Pharm Sci; 2016 Sep; 92():28-38. PubMed ID: 27343696 [TBL] [Abstract][Full Text] [Related]
7. Potential applications of polymeric microsphere suspension as subcutaneous depot for insulin. Shenoy DB; D'Souza RJ; Tiwari SB; Udupa N Drug Dev Ind Pharm; 2003 May; 29(5):555-63. PubMed ID: 12779285 [TBL] [Abstract][Full Text] [Related]
8. Preparation of insulin loaded PLGA-Hp55 nanoparticles for oral delivery. Cui FD; Tao AJ; Cun DM; Zhang LQ; Shi K J Pharm Sci; 2007 Feb; 96(2):421-7. PubMed ID: 17051590 [TBL] [Abstract][Full Text] [Related]
9. A new animal model for evaluation of long-term growth rate over one month by rhGH/PLGA microcapsule formulations. Takada S; Kurokawa T; Misaki M; Taira K; Yamagata Y J Pharm Pharmacol; 2003 Jul; 55(7):951-61. PubMed ID: 12906752 [TBL] [Abstract][Full Text] [Related]
10. HP55-coated capsule containing PLGA/RS nanoparticles for oral delivery of insulin. Wu ZM; Zhou L; Guo XD; Jiang W; Ling L; Qian Y; Luo KQ; Zhang LJ Int J Pharm; 2012 Apr; 425(1-2):1-8. PubMed ID: 22248666 [TBL] [Abstract][Full Text] [Related]
11. Influence of microencapsulation method and peptide loading on formulation of poly(lactide-co-glycolide) insulin nanoparticles. Kumar PS; Ramakrishna S; Saini TR; Diwan PV Pharmazie; 2006 Jul; 61(7):613-7. PubMed ID: 16889069 [TBL] [Abstract][Full Text] [Related]
12. Effect of PLGA hydrophilia on the drug release and the hypoglucemic activity of different insulin-loaded PLGA microspheres. Presmanes C; de Miguel L; Espada R; Alvarez C; Morales E; Torrado JJ J Microencapsul; 2011; 28(8):791-8. PubMed ID: 21967461 [TBL] [Abstract][Full Text] [Related]
13. Insulin-loaded PLGA/cyclodextrin large porous particles with improved aerosolization properties: in vivo deposition and hypoglycaemic activity after delivery to rat lungs. Ungaro F; d'Emmanuele di Villa Bianca R; Giovino C; Miro A; Sorrentino R; Quaglia F; La Rotonda MI J Control Release; 2009 Apr; 135(1):25-34. PubMed ID: 19154761 [TBL] [Abstract][Full Text] [Related]
14. Multi-arm histidine copolymer for controlled release of insulin from poly(lactide-co-glycolide) microsphere. Park W; Kim D; Kang HC; Bae YH; Na K Biomaterials; 2012 Dec; 33(34):8848-57. PubMed ID: 22959184 [TBL] [Abstract][Full Text] [Related]
15. In vitro uptake evaluation in Caco-2 cells and in vivo results in diabetic rats of insulin-loaded PLGA nanoparticles. Reix N; Parat A; Seyfritz E; Van der Werf R; Epure V; Ebel N; Danicher L; Marchioni E; Jeandidier N; Pinget M; Frère Y; Sigrist S Int J Pharm; 2012 Nov; 437(1-2):213-20. PubMed ID: 22940208 [TBL] [Abstract][Full Text] [Related]
16. Ultrasound-triggered regulation of blood glucose levels using injectable nano-network. Di J; Price J; Gu X; Jiang X; Jing Y; Gu Z Adv Healthc Mater; 2014 Jun; 3(6):811-6. PubMed ID: 24255016 [TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics and pharmacodynamics of controlled release insulin loaded PLGA microcapsules using dry powder inhaler in diabetic rats. Hamishehkar H; Emami J; Najafabadi AR; Gilani K; Minaiyan M; Hassanzadeh K; Mahdavi H; Koohsoltani M; Nokhodchi A Biopharm Drug Dispos; 2010 Mar; 31(2-3):189-201. PubMed ID: 20238376 [TBL] [Abstract][Full Text] [Related]
18. Evaluation of parenteral depot insulin formulation using PLGA and PLA microparticles. Naha PC; Kanchan V; Panda AK J Biomater Appl; 2009 Nov; 24(4):309-25. PubMed ID: 18987018 [TBL] [Abstract][Full Text] [Related]
19. Dextran-b-poly(lactide-co-glycolide) polymersome for oral delivery of insulin: In vitro and in vivo evaluation. Alibolandi M; Alabdollah F; Sadeghi F; Mohammadi M; Abnous K; Ramezani M; Hadizadeh F J Control Release; 2016 Apr; 227():58-70. PubMed ID: 26907831 [TBL] [Abstract][Full Text] [Related]
20. Insulin micropiles comprising biodegradable polymers for production of a long-term hypoglycemic effect. Fukushima K; Ito Y; Ishihata M; Sugioka N; Takada K J Drug Target; 2011 Apr; 19(3):212-8. PubMed ID: 20540650 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]